Inventor
PAVLAKIS GEORGE N
US34 patents
⚠️ This page may combine multiple inventors who share the name “PAVLAKIS GEORGE N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
19 patentsUS6794498B2Sep 21, 2004
Method of eliminating inhibitory/instability regions of mRNA
US HEALTH160 citations99
US6414132B1Jul 2, 2002
Method of eliminating inhibitory/instability regions of mRNA
US HEALTH155 citations99
US6291664B1Sep 18, 2001
Method of eliminating inhibitory/instability regions of mRNA
US HEALTH185 citations99
US6174666B1Jan 16, 2001
Method of eliminating inhibitory/instability regions from mRNA
US HEALTH214 citations99
US5972596AOct 26, 1999
Nucleic acid constructs containing HIV genes with mutated inhibitory/instability regions and methods of using same
US HEALTH133 citations99
US5965726AOct 12, 1999
Method of eliminating inhibitory/ instability regions of mRNA
US HEALTH290 citations99
US6770291B2Aug 3, 2004
Liposome complexes for increased systemic delivery
US HEALTH95 citations96
US6265548B1Jul 24, 2001
Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence
US HEALTH52 citations94
US6027881AFeb 22, 2000
Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence
US HEALTH77 citations94
US6656706B2Dec 2, 2003
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
US HEALTH15 citations92
US7001614B2Feb 21, 2006
Liposome complexes for increased systemic delivery
US HEALTH23 citations91
US6413544B1Jul 2, 2002
Liposome complexes for increased systemic delivery
US HEALTH32 citations91
US7833754B2Nov 16, 2010
IL-12 for expression in mammalian cell
US HEALTH21 citations87
US7608422B2Oct 27, 2009
Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhibitory/instability regions
US HEALTH4 citations74
US10428133B2Oct 1, 2019
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
US HEALTH3 citations73
US9546202B2Jan 17, 2017
Expression of IL-12 family heterodimers
US HEALTH3 citations73
US11339198B2May 24, 2022
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
US HEALTH0 citations62
US7288266B2Oct 30, 2007
Liposome complexes for increased systemic delivery
US HEALTH5 citations61
US6919442B1Jul 19, 2005
Nucleic acids comprising a post-transcriptional regulatory element (PRE) and their uses
US HEALTH2 citations54
PAVLAKIS GEORGE N
3 patentsUS9931377B2Apr 3, 2018
Cell expressing complexes of IL-15 and IL-15Ralpha
PAVLAKIS GEORGE N23 citations93
US8871191B2Oct 28, 2014
Use of IL-15 preparations to treat lymphopenia
PAVLAKIS GEORGE N18 citations89
US8076100B2Dec 13, 2011
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
PAVLAKIS GEORGE N3 citations62
NOVARTIS AG
3 patentsUS10335460B2Jul 2, 2019
IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions
NOVARTIS AG4 citations73
US11110150B2Sep 7, 2021
Complexes of IL-15 and IL-15Ralpha and uses thereof
NOVARTIS AG1 citations71
US10265382B2Apr 23, 2019
Complexes of IL-15 and IL-15Ralpha and uses thereof
NOVARTIS AG4 citations71
THE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES
2 patentsUS9790261B2Oct 17, 2017
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
THE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES10 citations92
US9725492B2Aug 8, 2017
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
THE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES13 citations92
FELBER BARBARA K
2 patentsTHE US SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
2 patentsUS10093710B2Oct 9, 2018
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
THE US SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES3 citations82
US9975937B2May 22, 2018
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
THE US SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES8 citations82